Silver Book Fact

Delaying the onset of Alzheimer’s by only 5 years could reduce the number of people with Alzheimer’s by almost 50% after 50 years.

Brookmeyer R, Gray S, Kawas C. Projections of Alzheimer’s Disease in the United States and the Public Health Impact of Delaying Disease Onset. Am J Public Health. 1998; 88(9): 1337-42. http://www.ajph.org/cgi/content/abstract/88/9/1337?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&author1=brookmeyer&searchid=1&FIRSTINDEX=0&sortspec=relevance&resourcetype=HWCIT

Reference

Title
Projections of Alzheimer’s Disease in the United States and the Public Health Impact of Delaying Disease Onset
Publication
Am J Public Health
Publication Date
1998
Authors
Brookmeyer R, Gray S, Kawas C
Volume & Issue
Volume 88, Issue 9
Pages
1337-42
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • A study of rasagiline mesylate in Parkinson’s disease patients showed improved motor fluctuations and other Parkinson’s disease symptoms.  
  • 2006 Medicines in Development for Neurologic Disorders  
  • Medicaid Costs, Slowed Progression  
  • In one study, despite a 4-fold increase in prescription drug spending, overall health spending for Alzheimer’s patients undergoing drug therapy went down by 1/3.  
  • Use of existing or new drugs/compounds for Alzheimer’s prevention could result in a delay of onset of between 2 and 5 years.